{"transactions":[{"id":28402,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T21:29:27.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":3572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":3572,"derivative":{"exercise_date":"2026-02-01","expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":3572},"source":{"system":"sec-edgar","filing":"0000059478-25-000059","document":"wk-form4_1739395756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000059/wk-form4_1739395756.xml","form_type":"4"}},{"id":28401,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2025-02-12T21:29:27.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":6828.871,"price":868.88,"value":5933469.43448,"ownership":{"direct":true},"balance_after":74209.769,"source":{"system":"sec-edgar","filing":"0000059478-25-000059","document":"wk-form4_1739395756.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000059/wk-form4_1739395756.xml","form_type":"4"}},{"id":29219,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2025-02-04T21:27:23.000Z","date":"2025-02-01","kind":"exercise","planned":false,"acquired":false,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2025-02-01","expiration_date":"2025-02-01","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000059478-25-000032","document":"wk-form4_1738704436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000032/wk-form4_1738704436.xml","form_type":"4"}},{"id":29218,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2025-02-04T21:27:23.000Z","date":"2025-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1457.102,"price":811.08,"value":1181826.29016,"ownership":{"direct":true},"balance_after":67380.898,"source":{"system":"sec-edgar","filing":"0000059478-25-000032","document":"wk-form4_1738704436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000032/wk-form4_1738704436.xml","form_type":"4"}},{"id":29217,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2025-02-04T21:27:23.000Z","date":"2025-02-01","kind":"exercise","planned":false,"acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68838,"source":{"system":"sec-edgar","filing":"0000059478-25-000032","document":"wk-form4_1738704436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000032/wk-form4_1738704436.xml","form_type":"4"}},{"id":46456,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2024-02-14T21:44:44.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":3269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":3269,"derivative":{"exercise_date":"2025-02-01","expiration_date":"2025-02-01","underlying":"Common Stock","underlying_shares":3269},"source":{"system":"sec-edgar","filing":"0000059478-24-000062","document":"wk-form4_1707947068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000062/wk-form4_1707947068.xml","form_type":"4"}},{"id":46455,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2024-02-14T21:44:44.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":5363,"price":737.26,"value":3953925.38,"ownership":{"direct":true},"balance_after":65569,"source":{"system":"sec-edgar","filing":"0000059478-24-000062","document":"wk-form4_1707947068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000062/wk-form4_1707947068.xml","form_type":"4"}},{"id":47666,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2024-02-02T21:20:49.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":4124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2024-02-01","expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":4124},"source":{"system":"sec-edgar","filing":"0000059478-24-000013","document":"wk-form4_1706908818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000013/wk-form4_1706908818.xml","form_type":"4"}},{"id":47665,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2024-02-02T21:20:49.000Z","date":"2024-02-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1844,"price":645.61,"value":1190504.84,"ownership":{"direct":true},"balance_after":60206,"source":{"system":"sec-edgar","filing":"0000059478-24-000013","document":"wk-form4_1706908818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000013/wk-form4_1706908818.xml","form_type":"4"}},{"id":47664,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2024-02-02T21:20:49.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":4124,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62050,"source":{"system":"sec-edgar","filing":"0000059478-24-000013","document":"wk-form4_1706908818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000013/wk-form4_1706908818.xml","form_type":"4"}},{"id":59128,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2023-02-14T22:12:35.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":4124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":4124,"derivative":{"exercise_date":"2024-02-01","expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":4124},"source":{"system":"sec-edgar","filing":"0000059478-23-000069","document":"wf-form4_167641273108663.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000069/wf-form4_167641273108663.xml","form_type":"4"}},{"id":59127,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2023-02-14T22:12:35.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":2500,"price":346.47,"value":866175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022."}],"balance_after":57926,"source":{"system":"sec-edgar","filing":"0000059478-23-000069","document":"wf-form4_167641273108663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000069/wf-form4_167641273108663.xml","form_type":"4"}},{"id":59126,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2023-02-14T22:12:35.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":2500,"price":342.76,"value":856900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022."}],"balance_after":60426,"source":{"system":"sec-edgar","filing":"0000059478-23-000069","document":"wf-form4_167641273108663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000069/wf-form4_167641273108663.xml","form_type":"4"}},{"id":59125,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2023-02-14T22:12:35.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":8562,"price":345.12,"value":2954917.44,"ownership":{"direct":true},"balance_after":62926,"source":{"system":"sec-edgar","filing":"0000059478-23-000069","document":"wf-form4_167641273108663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000069/wf-form4_167641273108663.xml","form_type":"4"}},{"id":59497,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2023-02-03T22:04:33.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":7264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2023-02-01","expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":7264},"source":{"system":"sec-edgar","filing":"0000059478-23-000043","document":"wf-form4_167546185628642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000043/wf-form4_167546185628642.xml","form_type":"4"}},{"id":59496,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2023-02-03T22:04:33.000Z","date":"2023-02-01","kind":"tax_withholding","acquired":false,"shares":3252,"price":344.15,"value":1119175.8,"ownership":{"direct":true},"balance_after":54364,"source":{"system":"sec-edgar","filing":"0000059478-23-000043","document":"wf-form4_167546185628642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000043/wf-form4_167546185628642.xml","form_type":"4"}},{"id":59495,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Pres, Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2023-02-03T22:04:33.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":7264,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57616,"source":{"system":"sec-edgar","filing":"0000059478-23-000043","document":"wf-form4_167546185628642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947823000043/wf-form4_167546185628642.xml","form_type":"4"}},{"id":71139,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2022-02-11T23:38:52.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":7264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":7264,"derivative":{"exercise_date":"2023-02-01","expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":7264},"source":{"system":"sec-edgar","filing":"0000059478-22-000056","document":"wf-form4_164462270168794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000056/wf-form4_164462270168794.xml","form_type":"4"}},{"id":71138,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2022-02-11T23:38:52.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":11348,"price":243.27,"value":2760627.96,"ownership":{"direct":true},"balance_after":50352,"source":{"system":"sec-edgar","filing":"0000059478-22-000056","document":"wf-form4_164462270168794.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000056/wf-form4_164462270168794.xml","form_type":"4"}},{"id":72138,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Neuroscience"}}],"security":"Restricted Stock Unit","published_at":"2022-02-03T22:09:32.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":9368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2022-02-01","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":9368},"source":{"system":"sec-edgar","filing":"0000059478-22-000032","document":"wf-form4_164392615619605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000032/wf-form4_164392615619605.xml","form_type":"4"}},{"id":72137,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2022-02-03T22:09:32.000Z","date":"2022-02-01","kind":"tax_withholding","acquired":false,"shares":4204,"price":245.39,"value":1031619.56,"ownership":{"direct":true},"balance_after":39004,"source":{"system":"sec-edgar","filing":"0000059478-22-000032","document":"wf-form4_164392615619605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000032/wf-form4_164392615619605.xml","form_type":"4"}},{"id":72136,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Neuroscience"}}],"security":"Common Stock","published_at":"2022-02-03T22:09:32.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":9368,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43208,"source":{"system":"sec-edgar","filing":"0000059478-22-000032","document":"wf-form4_164392615619605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947822000032/wf-form4_164392615619605.xml","form_type":"4"}},{"id":93840,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Restricted Stock Unit","published_at":"2021-02-11T01:48:41.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":9368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":9368,"derivative":{"exercise_date":"2022-02-01","expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":9368},"source":{"system":"sec-edgar","filing":"0000059478-21-000066","document":"wf-form4_161300810149825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000066/wf-form4_161300810149825.xml","form_type":"4"}},{"id":93839,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Common Stock","published_at":"2021-02-11T01:48:41.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":4718,"price":205.77,"value":970822.86,"ownership":{"direct":true},"balance_after":33840,"source":{"system":"sec-edgar","filing":"0000059478-21-000066","document":"wf-form4_161300810149825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000066/wf-form4_161300810149825.xml","form_type":"4"}},{"id":107915,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Common Stock","published_at":"2020-02-13T23:19:46.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":7079,"price":144.25,"value":1021145.75,"ownership":{"direct":true},"balance_after":29122,"source":{"system":"sec-edgar","filing":"0000059478-20-000048","document":"wf-form4_158163596956610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947820000048/wf-form4_158163596956610.xml","form_type":"4"}},{"id":111517,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Common Stock","published_at":"2019-10-28T19:11:59.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":1000,"price":108.84,"value":108840.0,"ownership":{"direct":true},"balance_after":22043,"source":{"system":"sec-edgar","filing":"0000059478-19-000289","document":"wf-form4_157228979250811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000289/wf-form4_157228979250811.xml","form_type":"4"}},{"id":120456,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Common Stock","published_at":"2019-02-07T00:53:44.000Z","date":"2019-02-04","kind":"grant","acquired":true,"shares":7246,"price":120.17,"value":870751.82,"ownership":{"direct":true},"balance_after":21043,"source":{"system":"sec-edgar","filing":"0000059478-19-000065","document":"wf-form4_154950080990103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000065/wf-form4_154950080990103.xml","form_type":"4"}},{"id":122137,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Restricted Stock Unit","published_at":"2018-12-04T20:14:08.000Z","date":"2018-12-02","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."}],"balance_after":0,"derivative":{"exercise_date":"2018-12-02","expiration_date":"2018-12-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000059478-18-000286","document":"wf-form4_154395442914579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000286/wf-form4_154395442914579.xml","form_type":"4"}},{"id":122136,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Common Stock","published_at":"2018-12-04T20:14:08.000Z","date":"2018-12-02","kind":"tax_withholding","acquired":false,"shares":3306,"price":118.64,"value":392223.84,"ownership":{"direct":true},"balance_after":13797,"source":{"system":"sec-edgar","filing":"0000059478-18-000286","document":"wf-form4_154395442914579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000286/wf-form4_154395442914579.xml","form_type":"4"}},{"id":122135,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11322,"kind":"person","name":"White Anne E.","position":1,"cik":"0001752313","reported_name":"White Anne E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Pres-Lilly Oncology"}}],"security":"Common Stock","published_at":"2018-12-04T20:14:08.000Z","date":"2018-12-02","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17103,"source":{"system":"sec-edgar","filing":"0000059478-18-000286","document":"wf-form4_154395442914579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000286/wf-form4_154395442914579.xml","form_type":"4"}}]}